Home > Press > UAlberta prostate cancer researcher and team developing 'homing beacon drugs' to target cancer cells
Abstract:
A medical researcher with the University of Alberta and his team just published their findings about their work on developing 'homing beacon drugs' that kill only cancer cells, not healthy ones, thanks to nano-technology.
John Lewis, the Frank and Carla Sojonky Chair in Prostate Cancer Research with the Faculty of Medicine & Dentistry, published his findings in the peer-reviewed journal, Nano Letters. He is also an associate professor in the Department of Oncology, a Fellow with the National Institute for Nanotechnology at the U of A and director of the Translational Prostate Cancer Research Group.
Lewis noted chemotherapy goes through the body and kills any cells that are dividing, even healthy ones - which is why cancer patients have immune system problems, hair loss, nausea and skin problems.
"We are developing smart drugs that determine which are the cancer cells and which aren't, then selectively kill only the cancer cells. The drugs look for a protein that is only found in cancer cells, not normal cells. This system acts like a homing beacon for tumours."
These drugs, tested to date in only animal lab models, could be used within a week of cancer diagnoses, predicts Lewis. The drugs would target cancerous cells throughout the body - attacking sneaky cancer cells that have already escaped and grown outside the site of the main tumour.
Lewis wasn't sure when these homing beacon drugs could be available for physicians to use with patients, but hopes his works paves the way for patient-centered therapies.
"If we can use 'smart' drugs that home in on tumours, we can dramatically decrease side effects for patients, lower the chance of recurrence, and hopefully increase the cancer survival rate."
Meanwhile, Lewis and his research team are continuing their work on trying to figure out what causes cancer cells to escape and spread from the main tumour site because the cells that move are different than the ones in the main tumour. They have pinpointed numerous genes that set these 'moving' cancer cells apart from the ones that stay put. Based on this research, they have come up with a drug that uses a 'tumour glue' to prevent these moving cancer cells from breaking apart from the main tumour, which prevents the spread of the cancer. Using knowledge gained from the 'tumour glue' drug, Lewis and his team are working to develop new blood tests to predict whether prostate and other cancers will spread.
####
For more information, please click here
Contacts:
Raquel Maurier
780-492-5986
Copyright ? University of Alberta Faculty of Medicine & Dentistry
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Flower Power to Purge Poison and Produce Platinum November 21st, 2012
New structures self-assemble in synchronized dance November 21st, 2012
Lumerical Products, Including FDTD Solutions, Now Compatible with Amazon EC2: All Lumerical products can now be easily and quickly accessed on the scalable infrastructure of the Amazon Elastic Compute Cloud (EC2) November 21st, 2012
Breakthrough Nanoparticle Halts Multiple Sclerosis: New nanotechnology can be used for Type 1 diabetes, food allergies and asthma November 21st, 2012
Govt.-Legislation/Regulation/Funding/Policy
Flower Power to Purge Poison and Produce Platinum November 21st, 2012
New structures self-assemble in synchronized dance November 21st, 2012
Breakthrough Nanoparticle Halts Multiple Sclerosis: New nanotechnology can be used for Type 1 diabetes, food allergies and asthma November 21st, 2012
Research Reveals Nanotechnology Simplifies Hydrogen Production for Clean Energy November 21st, 2012
Nanomedicine
Flower Power to Purge Poison and Produce Platinum November 21st, 2012
Breakthrough Nanoparticle Halts Multiple Sclerosis: New nanotechnology can be used for Type 1 diabetes, food allergies and asthma November 21st, 2012
Mentor Capital Signs $6M Nanotechnology Cancer LOI November 21st, 2012
Researchers build synthetic membrane channels out of DNA: Nanotech structures mimic nature's way of tunneling through cell walls November 20th, 2012
Discoveries
Breakthrough Nanoparticle Halts Multiple Sclerosis: New nanotechnology can be used for Type 1 diabetes, food allergies and asthma November 21st, 2012
King's College London finds rainbows on nanoscale: Big impact on solar cells, television screens November 21st, 2012
Research Reveals Nanotechnology Simplifies Hydrogen Production for Clean Energy November 21st, 2012
Nanotech Device Mimics Dog's Nose to Detect Explosives: Inspired by the biology of canine scent receptors, UC Santa Barbara scientists develop a chip capable of quickly identifying trace amounts of vapor molecules November 21st, 2012
Announcements
Research Reveals Nanotechnology Simplifies Hydrogen Production for Clean Energy November 21st, 2012
Mentor Capital Signs $6M Nanotechnology Cancer LOI November 21st, 2012
Nanotech Device Mimics Dog's Nose to Detect Explosives: Inspired by the biology of canine scent receptors, UC Santa Barbara scientists develop a chip capable of quickly identifying trace amounts of vapor molecules November 21st, 2012
Mirrorcle Technologies scanning MEMS mirrors deployed in portable OCT system November 21st, 2012
Source: http://www.nanotech-now.com/news.cgi?story_id=46419
mark davis marine urination video cadillac ats bain capital marines urinating haley barbour olivier martinez
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.